dasatinib dr.reddy's dasatinib 100 mg film coated tablet blister pack
dr reddys laboratories australia pty ltd - dasatinib propylene glycol, quantity: 116 mg (equivalent: dasatinib, qty 100 mg) - tablet, film coated - excipient ingredients: hydrogenated castor oil; lactose; silicon dioxide; magnesium stearate; croscarmellose sodium; microcrystalline cellulose; titanium dioxide; hypromellose; triacetin - dasatinib dr.reddy's is indicated for the treatment of adults aged 18 years or over with: ? newly diagnosed philadelphia chromosome positive (ph+) chronic myeloid leukaemia in the chronic phase. ? chronic, accelerated or myeloid or lymphoid blast phase chronic myeloid leukaemia with resistance or intolerance to prior therapy including imatinib. ? newly diagnosed philadelphia chromosome positive acute lymphoblastic leukaemia integrated with chemotherapy. ? philadelphia chromosome positive acute lymphoblastic leukaemia with resistance or intolerance to prior therapy.,dasatinib dr.reddy's is indicated for the treatment of paediatric patients with: ? ph+ cml in the chronic phase. ? newly diagnosed ph+ all in combination with chemotherapy.
dasatinib dr.reddy's dasatinib 50 mg film coated tablet blister pack
dr reddys laboratories australia pty ltd - dasatinib propylene glycol, quantity: 58 mg (equivalent: dasatinib, qty 50 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; croscarmellose sodium; hydrogenated castor oil; magnesium stearate; hypromellose; titanium dioxide; lactose; triacetin; silicon dioxide - dasatinib dr.reddy's is indicated for the treatment of adults aged 18 years or over with: ? newly diagnosed philadelphia chromosome positive (ph+) chronic myeloid leukaemia in the chronic phase. ? chronic, accelerated or myeloid or lymphoid blast phase chronic myeloid leukaemia with resistance or intolerance to prior therapy including imatinib. ? newly diagnosed philadelphia chromosome positive acute lymphoblastic leukaemia integrated with chemotherapy. ? philadelphia chromosome positive acute lymphoblastic leukaemia with resistance or intolerance to prior therapy.,dasatinib dr.reddy's is indicated for the treatment of paediatric patients with: ? ph+ cml in the chronic phase. ? newly diagnosed ph+ all in combination with chemotherapy.
reddy-dasatinib comprimé
dr reddy's laboratories ltd - dasatinib (dasatinib (s)-propylèneglycol) - comprimé - 20mg - dasatinib (dasatinib (s)-propylèneglycol) 20mg - antineoplastic agents
reddy-dasatinib comprimé
dr reddy's laboratories ltd - dasatinib (dasatinib (s)-propylèneglycol) - comprimé - 50mg - dasatinib (dasatinib (s)-propylèneglycol) 50mg - antineoplastic agents
reddy-dasatinib comprimé
dr reddy's laboratories ltd - dasatinib (dasatinib (s)-propylèneglycol) - comprimé - 70mg - dasatinib (dasatinib (s)-propylèneglycol) 70mg - antineoplastic agents
reddy-dasatinib comprimé
dr reddy's laboratories ltd - dasatinib (dasatinib (s)-propylèneglycol) - comprimé - 80mg - dasatinib (dasatinib (s)-propylèneglycol) 80mg - antineoplastic agents
reddy-dasatinib comprimé
dr reddy's laboratories ltd - dasatinib (dasatinib (s)-propylèneglycol) - comprimé - 100mg - dasatinib (dasatinib (s)-propylèneglycol) 100mg - antineoplastic agents
reddy-dasatinib comprimé
dr reddy's laboratories ltd - dasatinib (dasatinib (s)-propylèneglycol) - comprimé - 140mg - dasatinib (dasatinib (s)-propylèneglycol) 140mg - antineoplastic agents
dasatinib teva
actavis d.o.o. beograd - dasatinib - film tableta - 100mg
dasatinib teva
actavis d.o.o. beograd - dasatinib - film tableta - 20mg